Monday, 17 October 2011 07:05

BASi Adds To Senior Management Team

BASi (Bioanalytical Systems Inc.) (NASDAQ: BASi,) has announced an addition to its senior management team to enhance the company’s focus on the demand for discovery services.

Evansville general manager John Devine Jr., BS, DABT, has been promoted to vice president of non-clinical services.

Devine has been with BASi for more than 20 years. For the past four years Devine has been responsible for overseeing the Evansville facility with a staff of 80 technicians, study directors and administrative personnel. He started at the facility as a lab technician while studying at the University of Southern Indiana. Devine is a diplomate of the American Board of Toxicology and is known for his research and expertise in the industry.

"John has successfully developed the toxicology service in Evansville, consistently growing the business each year," said BASi president and CEO Anthony S. Chilton Ph.D. "In addition to being responsible for the toxicology business, John will be responsible for the development of the in vivo discovery service business." Those services are being expanded and relocated in 2012 to BASi West Lafayette in the Purdue Research Park of West Lafayette.

Assistant manager and director of analytical services, Phillip Downing, has been named the new general manager of BASi Evansville.

About BASi
BASi is a drug discovery and development services company providing contract research services and instruments to the world's leading pharmaceutical companies and medical research organizations. The company, based in the Purdue Research Park, focuses on developing innovative services and products that increase efficiency and reduce the cost of taking new and generic drugs to market. Visit http://www.BASInc.com for more about BASi.

Read 893 times Last modified on Tuesday, 31 January 2012 13:51

Leave a comment

Make sure you enter the (*) required information where indicated. HTML code is not allowed.

Want more? Visit...

Videos

  • ICON- Partnerships 12
    ICON- Partnerships 12 Steven Cutler, Group President of ICON discusses the launch of ICON's new acquisition of Firecrest at Partnerships in Clinical Trials 2012. Facing the continuing challenge of not only monitoring and…
    Read more...
  • ICON- Partnerships 12
    ICON- Partnerships 12 Steven Cutler, Group President of ICON discusses their exciting new partnership with Roche at Partnerships In Clinical Trials 2012. Medical imaging has always been a strong department within ICON. ICON…
    Read more...
  • ERT- Partnerships 12
    ERT- Partnerships 12 John Blakely, Executive Vice President and Chief Commercial Officer for ERT discusses the new trend in clinical research at Partnerships in Clinical Trials 2012 - the melding of objective and…
    Read more...
  • Chiltern- Partnerships 12
    Chiltern- Partnerships 12 Marcelo Piccirillo, Senior Clinical Research Physician for Chiltern, discusses new trends in gastrointestinal clinical development at Partnerships in Clinical Trials 2012. Current hot spots for clinical development in the field…
    Read more...
  • Blinded Diagnostics - Partnerships 12
    Blinded Diagnostics - Partnerships 12 Paul Savuto, President and CFO, and Steven Karrupan, CEO, from Blinded Diagnostics discuss Point of Care Technology at Partnerships in Clinical Trials 2012. Point of care (or decentralized testing) offers…
    Read more...
  • American Airlines - IQPC 2011
    American Airlines - IQPC 2011 American Airlines has globally launched a passive solutions that gives a new alternative to pharmaceutical manufacturers.
    Read more...

Podcasts